Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: A Pilot Study on the Efficacy of 2% Cholesterol Cream in Preventing Transepidermal Water Loss and Clinical Symptoms in Mild to Moderate Atopic Dermatitis [NA]

View source ↗

Summary

A pilot study sponsored by the Institute of Dermatology in Thailand is evaluating whether 2% cholesterol cream can prevent transepidermal water loss and improve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 2% cholesterol cream (cholesterol cream)

Snippet

Sponsor: Institute of Dermatology, Thailand | Conditions: Atopic Dermatitis (AD), Cholesterol | NA | Status: ENROLLING_BY_INVITATION